| Followers | 842 |
| Posts | 122793 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Monday, December 07, 2015 12:40:22 PM
http://finance.yahoo.com/news/momenta-pharmaceuticals-appoints-matthew-p-153000611.html
Momenta Pharmaceuticals, Inc….today announced the appointment of Matt Ottmer as Chief Operating Officer.
…Mr. Ottmer most recently served as Senior Vice President, Strategy & Emerging Businesses at Biogen, Inc. where he led cross-functional assessment, prioritization, and implementation planning across a broad range of value-creating opportunities including internal capability building, alliances and in-licenses, and mergers and acquisitions. Before his promotion to Senior Vice President, Mr. Ottmer held positions of increasing responsibility at Biogen from 1999 to 2015 including Head of Tysabri Business, Chief of Staff to the CEO, President of Syntonix Pharmaceuticals, Inc. (a wholly owned subsidiary of Biogen), and Vice President, Global Operations. He received a Bachelor of Arts degree in political science from the University of Michigan and a Master’s in Business Administration from Northwestern University’s Kellogg School of Management.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
